DAIC

DECEMBER 8, 2023

a medical device company dedicated to improving outcomes for patients with cardiac and renal impairment, announced the enrollment of the first patients in the company's IDE pivotal trial. These patients have very poor outcomes in terms of death and rehospitalization and therefore new therapy options are critically needed," stated Dr. Chehab.

Technology 113

Technology Heart Failure Heart Transplant Transplant 113

Stroke Journal

FEBRUARY 1, 2024

Methods:Data were retrieved from a CMS Qualified Entity housing healthcare utilization data for ≥80% of the Texas state population (100% of Medicare Fee-for-Service). Analytical sample included all Medicare enrollees with a primary discharge diagnosis (AIS or ICH) from 2016 to 2020. and 82.3% (Panel D).Conclusion:Post

Medicare 40

Medicare Hemorrhage Inpatient Nursing 40

DAIC

JULY 25, 2024

The CardiAMP clinical development for heart failure is supported by the Maryland Stem Cell Research Fund and is reimbursed by Center for Medicare and Medicaid Services (CMS) for both treatment and control procedures. CAUTION - Limited by United States law to investigational use.

Heart Failure 111

Heart Failure Quality of Life CMS Reimbursement 111

DAIC

JUNE 4, 2024

To improve outcomes and be in compliance with new regulations, it's crucial to better identify and address these issues during the recovery period. Stroke recovery is a challenging process that extends for months after hospital discharge. This missing puzzle piece matters now more than ever.

Strokes 115

Strokes Stroke Innovation Research 115

American College of Cardiology

FEBRUARY 1, 2025

Cardiovascular medications frequently lead this category, often contributing to adverse clinical outcomes, including emergency department visits and hospitalizations. In recent years, numerous health care challenges have been tackled, some making headlines, while others quietly escalate under the radar – like polypharmacy.

Cardiovascular Disease 40

Cardiovascular Disease Coronary Artery Disease CMS Hospital 40

Stroke Journal

JANUARY 30, 2025

We longitudinally followed the patients by linking the registry data to the Center for Medicare&Medicaid Service (CMS) claims data.

Medicare 40

Medicare CMS Medicaid Myocardial Infarction 40

Stroke Journal

JANUARY 30, 2025

We evaluated the influence of early (30-day) post-acute care (PAC) pathways on 1-year HT.Methods:We analyzed a cohort of Medicare AIS patients at a 7-hospital stroke certified health system (2016 to 2020). Random forest (RF) classification and regression models were built to evaluate predictors of 1-YR outcomes (HR, death, and HT).

Strokes 40

Strokes Stroke Medicare CMS 40

Stroke Journal

JANUARY 30, 2025

Conclusion:Cluster analyses can elucidate high-risk patient profiles and guide in identifying intervenable targets and prioritizing provision of appropriate care, including rehabilitation, to optimize long-term patient outcomes. Post acute care at an inpatient rehabilitation facility minimized the risk of low HT (vs. vs. 28.5%) (Fig.

Inpatient 40

Inpatient Strokes Stroke CMS 40

GEMMS

MARCH 7, 2024

In late 2023, CMS released the 2024 Medicare Physician Fee Schedule (MPFS) Final Rule, ushering in key policy changes for the Quality Payment Program (QPP). Report 6 measures, including one Outcome or other High Priority measure for 12 months on at least 70% of eligible encounters to receive a score based on 2023 National Benchmarks.

Medicare 52

Medicare CMS Document Technology 52

Society of Thoracic Surgeons - Technology

OCTOBER 21, 2021

Removing these barriers would allow surgeons, physicians, hospitals, health systems, and others to conduct longitudinal analyses and gain new insights into long-term outcomes for patients undergoing procedures such as coronary artery bypass grafting (CABG)—the most common operation performed by cardiac surgeons.

Technology 40

Technology Coronary Artery Bypass Graft Cardiothoracic Aortic valve 40

DAIC

JANUARY 27, 2025

13, 2025 Medtronic recentlyannounced that the Centers for Medicare & Medicaid Services (CMS) is opening a national coverage analysis (NCA) on renal denervation, a process that will allow the agency to review and develop a national Medicare coverage policy for renal denervation procedures for patients with hypertension.

CMS 52

CMS Blood Pressure Medicare Hypertension 52

DAIC

JANUARY 13, 2025

Additionally, the company announced that the Centers for Medicare & Medicaid Services (CMS) has granted Category B approval for the investigational device exemption (IDE) study, ensuring Medicare coverage for the device, related and routine items, and services for the ELITE-BTK trial. Secemsky, M.D.,

Peripheral Arterial Disease 52

Peripheral Arterial Disease CMS Medicare Medicaid 52

The Beat Blog

AUGUST 12, 2022

Elliott Fisher during a 2006 public meeting with the Medicare Payment Advisory Committee (MedPAC). Then, six years later in 2012, The Patient Protection and Affordable Care Act (ACA) authorized the use of Accountable Care Organizations (ACOs) to improve the safety and quality of care and reduce health care costs in Medicare.

Medicare 52

Medicare Nursing Health Disparities Cardiovascular Disease 52